TAG:
test utilization
Professional Management Does Get Results
By R. Lewis Dark | From the Volume VII No. 11 – July 31, 2000 Issue
IF YOU TAKE THE TIME TO STUDY THE FINANCIAL PERFORMANCE of certain public laboratories in 1999 and into 2000, you will be struck by the strong growth and profit numbers. That is contrary to the popular wisdom, which says that the clinical lab industry is in financial doldrums. But the strong financi…
Investors Returning To Lab Industry
By R. Lewis Dark | From the Volume VII No. 9 – June 19, 2000 Issue
SOMETHING BIG IS HAPPENING to the clinical laboratory industry and the anatomic pathology profession. For the first time in six or seven years, the investment community is paying close attention to the laboratory industry. This should be a welcome development for commercial lab owners and anatomic …
War College Identifies Emerging Lab Trends
By Robert Michel | From the Volume VII No. 8 – May 30, 2000 Issue
CEO SUMMARY: Disruptive technologies and the arrival of healthcare E-commerce were two common themes which emerged from this year’s Executive War College on Laboratory and Pathology Management. Consensus by faculty and attendees alike was that every lab organization should have an Inter…
SBCL Inks National Pact With Aetna US Healthcare
By Robert Michel | From the Volume V No. 14 – October 19, 1998 Issue
CEO SUMMARY: As a corporate strategy, SmithKline Beecham Clinical Laboratories wants national contracts and exclusive provider status. The Aetna U.S. Healthcare agreement is SmithKline’s latest victory. Both companies are moving rapidly to implement the contract. In many cities where Ae…
Blunt Talk From HMO Blue’s Ancillary Contracts Manager
By Robert Michel | From the Volume V No. 11 – August 17, 1998 Issue
CEO SUMMARY: By now, most clinical laboratory executives and pathologists have discovered a new fact of life: provider status with managed care organizations is a critical success factor. Without provider status, the laboratory is denied access to patients and the reimbursement associated…
Unrealized Gains Targeted By Premier’s Lab Initiative
By Robert Michel | From the Volume V No. 9 – July 6, 1998 Issue
CEO SUMMARY: In part one of this exclusive interview, Premier’s John Biggers described the reasons why the 1,700 hospital consortium developed a strategic services program for clinical laboratories. In this final installment, Biggers provides insight as to how the program will work and …
Premier Explains Reasons It Sees Lab As Strategic
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
CEO SUMMARY: Premier’s strategic alliance with Quest Diagnostics Incorporated represents a fundamental shift in the marketplace for hospital-based clinical laboratory services. This was a project developed by Premier, in response to its evaluation of marketplace trends affecting hospita…
SmithKline May Merge With Glaxo Wellcome
By Robert Michel | From the Volume V No. 2 – February 9, 1998 Issue
CEO SUMMARY: Both companies confirm that merger talks are under way. The merger is another example of consolidation within the healthcare industry, and is expected to trigger mergers between other drug companies. Fate of SmithKline’s clinical laboratory division in the merger with Glaxo…
“State of Lab Industry” Reveals Radical Change
By Robert Michel | From the Volume IV No. 17 – December 8, 1997 Issue
CEO SUMMARY: Pick your trend: declining reimbursement, consolidation, clinical integration, downsizing, and capitated reimbursement. These trends all continued to shape the way laboratories organized to provide services. But 1997’s wildcard was the federal government. Between investigat…
Joint Venture In Phoenix To Be Copied Elsewhere
By Robert Michel | From the Volume IV No. 11 – August 4, 1997 Issue
CEO SUMMARY: Look for the Quest-Sonora joint venture to be followed by others in coming months. Competition and marketplace realities are forcing the three national laboratories to respond with groundbreaking strategies. Hospital laboratory partners in these deals can reap significant ben…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized